248 related articles for article (PubMed ID: 35965101)
21. The microRNA target site landscape is a novel molecular feature associating alternative polyadenylation with immune evasion activity in breast cancer.
Kim S; Bai Y; Fan Z; Diergaarde B; Tseng GC; Park HJ
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32844230
[TBL] [Abstract][Full Text] [Related]
22. CFIm25 regulates human stem cell function independently of its role in mRNA alternative polyadenylation.
Ran Y; Huang S; Shi J; Feng Q; Deng Y; Xiang AP; Yao C
RNA Biol; 2022; 19(1):686-702. PubMed ID: 35491945
[TBL] [Abstract][Full Text] [Related]
23. Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs.
Kubo T; Wada T; Yamaguchi Y; Shimizu A; Handa H
Nucleic Acids Res; 2006; 34(21):6264-71. PubMed ID: 17098938
[TBL] [Abstract][Full Text] [Related]
24. Involved microRNAs in alternative polyadenylation intervene in breast cancer via regulation of cleavage factor "CFIm25".
Tamaddon M; Shokri G; Hosseini Rad SMA; Rad I; Emami Razavi À; Kouhkan F
Sci Rep; 2020 Jul; 10(1):11608. PubMed ID: 32665581
[TBL] [Abstract][Full Text] [Related]
25. Alternative polyadenylation reprogramming of MORC2 induced by NUDT21 loss promotes KIRC carcinogenesis.
Tan Y; Zheng T; Su Z; Chen M; Chen S; Zhang R; Wang R; Li K; Na N
JCI Insight; 2023 Sep; 8(18):. PubMed ID: 37737260
[TBL] [Abstract][Full Text] [Related]
26. Pre-messenger RNA cleavage factor I (CFIm): potential role in alternative polyadenylation during spermatogenesis.
Sartini BL; Wang H; Wang W; Millette CF; Kilpatrick DL
Biol Reprod; 2008 Mar; 78(3):472-82. PubMed ID: 18032416
[TBL] [Abstract][Full Text] [Related]
27. CFIm25 in Solid Tumors: Current Research Progress.
Sun X; Li J; Sun X; Liu W; Meng X
Technol Cancer Res Treat; 2020; 19():1533033820933969. PubMed ID: 32643564
[TBL] [Abstract][Full Text] [Related]
28. The role of NUDT21 in microRNA-binging sites of EZH2 gene increases the of risk preeclampsia.
Lang X; Zhao W; Huang D; Liu W; Shen H; Xu L; Xu S; Huang Y; Cheng W
J Cell Mol Med; 2019 May; 23(5):3202-3213. PubMed ID: 30883033
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation.
Xing Y; Chen L; Gu H; Yang C; Zhao J; Chen Z; Xiong M; Kazobinka G; Liu Y; Hou T
Oncogene; 2021 Mar; 40(11):2051-2064. PubMed ID: 33619322
[TBL] [Abstract][Full Text] [Related]
30. Recurrent tumor-specific regulation of alternative polyadenylation of cancer-related genes.
Xue Z; Warren RL; Gibb EA; MacMillan D; Wong J; Chiu R; Hammond SA; Yang C; Nip KM; Ennis CA; Hahn A; Reynolds S; Birol I
BMC Genomics; 2018 Jul; 19(1):536. PubMed ID: 30005633
[TBL] [Abstract][Full Text] [Related]
31. On the function and relevance of alternative 3'-UTRs in gene expression regulation.
Pereira-Castro I; Moreira A
Wiley Interdiscip Rev RNA; 2021 Sep; 12(5):e1653. PubMed ID: 33843145
[TBL] [Abstract][Full Text] [Related]
32. APA-Scan: detection and visualization of 3'-UTR alternative polyadenylation with RNA-seq and 3'-end-seq data.
Fahmi NA; Ahmed KT; Chang JW; Nassereddeen H; Fan D; Yong J; Zhang W
BMC Bioinformatics; 2022 Sep; 23(Suppl 3):396. PubMed ID: 36171568
[TBL] [Abstract][Full Text] [Related]
33. A compendium of conserved cleavage and polyadenylation events in mammalian genes.
Wang R; Zheng D; Yehia G; Tian B
Genome Res; 2018 Oct; 28(10):1427-1441. PubMed ID: 30143597
[TBL] [Abstract][Full Text] [Related]
34. Emerging roles of alternative cleavage and polyadenylation (APA) in human disease.
Dharmalingam P; Mahalingam R; Yalamanchili HK; Weng T; Karmouty-Quintana H; Guha A; A Thandavarayan R
J Cell Physiol; 2022 Jan; 237(1):149-160. PubMed ID: 34378793
[TBL] [Abstract][Full Text] [Related]
35. TREND-DB-a transcriptome-wide atlas of the dynamic landscape of alternative polyadenylation.
Marini F; Scherzinger D; Danckwardt S
Nucleic Acids Res; 2021 Jan; 49(D1):D243-D253. PubMed ID: 32976578
[TBL] [Abstract][Full Text] [Related]
36. Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling.
Brumbaugh J; Di Stefano B; Wang X; Borkent M; Forouzmand E; Clowers KJ; Ji F; Schwarz BA; Kalocsay M; Elledge SJ; Chen Y; Sadreyev RI; Gygi SP; Hu G; Shi Y; Hochedlinger K
Cell; 2018 Jan; 172(1-2):106-120.e21. PubMed ID: 29249356
[TBL] [Abstract][Full Text] [Related]
37. Stiff matrix instigates type I collagen biogenesis by mammalian cleavage factor I complex-mediated alternative polyadenylation.
Zhou Z; Qu J; He L; Zhu Y; Yang SZ; Zhang F; Guo T; Peng H; Chen P; Zhou Y
JCI Insight; 2020 Feb; 5(3):. PubMed ID: 31935199
[TBL] [Abstract][Full Text] [Related]
38. 3' UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk.
Park HJ; Ji P; Kim S; Xia Z; Rodriguez B; Li L; Su J; Chen K; Masamha CP; Baillat D; Fontes-Garfias CR; Shyu AB; Neilson JR; Wagner EJ; Li W
Nat Genet; 2018 Jun; 50(6):783-789. PubMed ID: 29785014
[TBL] [Abstract][Full Text] [Related]
39. NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1.
Jonnakuti VS; Ji P; Gao Y; Lin A; Chu Y; Elrod N; Huang KL; Li W; Yalamanchili HK; Wagner EJ
J Neurooncol; 2023 Jul; 163(3):623-634. PubMed ID: 37389756
[TBL] [Abstract][Full Text] [Related]
40. The mRNA Export Receptor NXF1 Coordinates Transcriptional Dynamics, Alternative Polyadenylation, and mRNA Export.
Chen S; Wang R; Zheng D; Zhang H; Chang X; Wang K; Li W; Fan J; Tian B; Cheng H
Mol Cell; 2019 Apr; 74(1):118-131.e7. PubMed ID: 30819645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
